Evidence map›Paper›PMID 35519825›Full record

ArticleHGG advances2022

Powerful eQTL mapping through low-coverage RNA sequencing.

Tommer Schwarz, Toni Boltz, Kangcheng Hou, Merel Bot, Chenda Duan, Loes Olde Loohuis, Marco P Boks, René S Kahn, Roel A Ophoff, Bogdan Pasaniuc

Open access · goldAbstract read
In one paragraph

Article in HGG advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Tommer SchwarzBioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, USA.
Toni BoltzDepartment of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Kangcheng HouBioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, USA.
Merel BotCenter for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Chenda DuanDepartment of Computer Science, University of California, Los Angeles, Los Angeles, CA, USA.
Loes Olde LoohuisDepartment of Psychiatry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Marco P BoksDepartment of Psychiatry, Brain Center University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands.
René S KahnDepartment of Psychiatry, Brain Center University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands.
Roel A OphoffBioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, USA.
Bogdan PasaniucBioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, USA.
University of California, Los Angeles · USUtrecht University · NL

Funding

Training Grant in Genomic Analysis and InterpretationT32HG002536 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Valerie A Arboleda, Harold Pimentel · 2002 to 2026
$8.6M
Joint genomic and statistical analyses of schizophrenia and bipolar to decipher genetic susceptibilityR01MH115676 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Roel A Ophoff, Bogdan Pasaniuc · 2018 to 2026
$5.9M
Training Grant in Neurobehavioral GeneticsT32NS048004 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E, OPHOFF, ROEL A · 2004 to 2025
$5.8M
NHGRI NIH HHS T32 HG002536NIMH NIH HHS R01 MH115676NINDS NIH HHS T32 NS048004
6 · The paper itself

Abstract

Mapping genetic variants that regulate gene expression (eQTL mapping) in large-scale RNA sequencing (RNA-seq) studies is often employed to understand functional consequences of regulatory variants. However, the high cost of RNA-seq limits sample size, sequencing depth, and, therefore, discovery power in eQTL studies. In this work, we demonstrate that, given a fixed budget, eQTL discovery power can be increased by lowering the sequencing depth per sample and increasing the number of individuals sequenced in the assay. We perform RNA-seq of whole-blood tissue across 1,490 individuals at low coverage (5.9 million reads/sample) and show that the effective power is higher than that of an RNA-seq study of 570 individuals at moderate coverage (13.9 million reads/sample). Next, we leverage synthetic datasets derived from real RNA-seq data (50 million reads/sample) to explore the interplay of coverage and number individuals in eQTL studies, and show that a 10-fold reduction in coverage leads to only a 2.5-fold reduction in statistical power to identify eQTLs. Our work suggests that lowering coverage while increasing the number of individuals in RNA-seq is an effective approach to increase discovery power in eQTL studies.

Indexed as

association testingeQTL mappinglow coverageRNA-seq

Identifiers

PMID35519825
PMCPMC9062329
OpenAlexW4226371480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.